当前位置:首页 - 行情中心 - 派林生物(000403) - 财务分析

派林生物

(000403)

  

流通市值:152.62亿  总市值:162.96亿
流通股本:6.85亿   总股本:7.31亿

派林生物(000403)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润5.43亿元,每股收益0.74元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益782482.69万元,未分配利润220894.43万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产905321.63万元,负债122838.94万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入1,890,265,336.271,136,178,207.09435,640,719.292,328,723,280.44
营业总成本1,279,639,389.94772,121,600.72297,485,500.881,639,495,501.1
营业利润638,752,175.75382,496,851.53149,114,003.51695,187,632.41
利润总额619,546,468.66370,852,765.45140,949,650.07688,108,822.6
净利润542,758,460.07326,975,804.17121,869,775.56611,472,470.99
其他综合收益-5,639.913,460.41,014.211,039.38
综合收益总额542,752,820.16326,979,264.57121,870,789.76611,483,510.37
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计3,542,327,499.323,419,669,292.383,441,910,520.513,426,074,653.6
非流动资产合计5,510,888,803.655,417,007,965.655,275,896,432.445,204,399,430.93
资产总计9,053,216,302.978,836,677,258.038,717,806,952.958,630,474,084.53
流动负债合计871,456,614.84920,173,992.14859,095,386.9922,194,565.38
非流动负债合计356,932,834.4307,449,967.75314,161,424.24286,415,637.35
负债合计1,228,389,449.241,227,623,959.891,173,256,811.141,208,610,202.73
归属于母公司股东权益合计7,831,710,847.177,615,971,397.347,551,538,502.257,428,649,258.06
股东权益合计7,824,826,853.737,609,053,298.147,544,550,141.817,421,863,881.8
负债和股东权益合计9,053,216,302.978,836,677,258.038,717,806,952.958,630,474,084.53
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计1,898,641,784.431,226,861,772.77564,474,916.42,587,523,845.94
经营活动现金流出小计1,671,107,587.891,114,003,467.63616,337,267.81,908,517,515.34
经营活动产生的现金流量净额227,534,196.54112,858,305.14-51,862,351.4679,006,330.6
投资活动现金流入小计1,004,387,646.63759,489,868.45181,896,596.18836,502,637.27
投资活动现金流出小计1,845,936,861.431,340,894,525.81622,268,521.761,125,713,935.01
投资活动产生的现金流量净额-841,549,214.8-581,404,657.36-440,371,925.58-289,211,297.74
筹资活动现金流入小计366,326,135.38226,625,911.31117,675,001.94446,621,746.99
筹资活动现金流出小计426,976,688.04336,884,424.4566,075,930.58408,384,849.88
筹资活动产生的现金流量净额-60,650,552.66-110,258,513.1451,599,071.3638,236,897.11
汇率变动对现金及现金等价物的影响-23,319.1513,668.713,817.82-23,429
现金及现金等价物净增加额-674,688,890.07-578,791,196.65-440,631,387.8428,008,500.97
期末现金及现金等价物余额753,590,120.03849,487,813.45987,647,622.31,428,279,010.1
最新报告期:2024-11-01
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
华鑫证券吴景欢,胡博新1.061.251.462024-11-01
中邮证券陈成,蔡明子1.071.291.502024-10-31
华源证券李强1.051.261.462024-10-30
民生证券王班1.051.251.432024-10-29
国泰君安丁丹1.061.281.542024-10-29
TOP↑